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Introduction 
Schizophrenia is a mental disorder that 
comes with a range of severe cognitive 
and social	 deficits. The pathophysiology 
of schizophrenia is still largely unknown 
and continues to be widely studied. It is 
believed	 that a	 combination of 
genes, environmental	 factors,	 and 
psychosocial factors contribute 
to schizophrenia (World Health 
Organization,	 2021). 
• Schizophrenia is one 
of the top	 15 leading 
causes of disability 
• The estimated	 
average potential life 
lost for individuals 
with	 schizophrenia in	 
the U.S. is 28.5 years 
• Comorbidities 
contribute to higher 
premature mortality 
rate 
• An	 estimated	 4.9% of 
people with	 
schizophrenia die by 
suicide (National 
Institute of Mental 
Health,	 2021) 




and thought disorder,	 
impaired ability to function,	 
psychosis,	 reduced 
expression of emotions,	 
reduced motivation to 
accomplish goals,	 difficulty 
in social relationships,	 
motor and cognitive 
impairment. Research 
shows	 that	 schizophrenia 
affects men and women 
equally,	 but has an earlier 
onset in males. Symptoms 
typically start	 in late 
adolescence or early 
adulthood. Cognitive 
impairment and unusual	 
behaviors sometimes 
appear in childhood. 
Schizophrenia is often 







evidence shows that 
symptoms map onto at
least two domains : 














alogia, defined as 
reduction in outward 
expression and speech 
(Begue et al,	 2020) 
(PsychMentalHealthNP.com) 
Pathophysiology 
It is postulated that the pathophysiology of schizophrenia involves
interactions between genetic predisposition and epigenetic
mechanisms. These interactions result in altered gene ex ression, which 
results in changes in behavior (Dean et al., 2016). The impact of acute 
psychosocial stress is implicated in the stress-mediated pathway of 
schizophrenia.
The complete function of dopamine and schizophrenia is not yet 
understood, but they believe more research would help improve 
treatment. There is strong support for dopamine dysfunction in 
schizophrenia through clinical imaging studies that point to dopamine 
as central in development and expression of psychotic symptoms.
Developing a more complete neurobiological framework of dopamine 
and its disruption in schizophrenia could lead to a better understanding
for interpreting clinical findings and developing new treatments 
(Sonnenschein et al, 2020).
There is evidence that abnormal serotonergic activity is involved in
the pathophysiology of schizophrenia. The serotonergic system has a 
role in cortical development, mood, cognition and impulse control (
Dean et al, 2016). Muscarinic receptors are another area being
researched. Changes in levels of muscarinic receptors are likely to have 
an effect on central nervous system activity, and understanding the
changes in muscarinic receptor levels in patients with schizophrenia can 
help us to understand how these changes may cause symptoms (Dean et
al, 2016).
The challenge is to increase our understanding of the molecular 
pathophysiology of schizophrenia which could allow new drugs to be
identified and developed so that treatment of a disorder which has been 
difficult to treat can be advanced. 
Treatment Conclusions Nursing Implication 
It is widely concluded that more research isPatient care is best suited with a Nurses are charged withcalled for and could contribute to bettercombination of cognitive-based providing evidence-based	outcomes with schizophrenia. While muchtherapy and medications. progress has been made to understand practices and	 always strivingAssessments should systematically behavioral, cognitive and neural mechanisms of to improve the lives of theirinclude behavioral, schizophrenia, the translation to treatment has patients. Treatingnot been made and still remains a critical need
for patients. schizophrenia patients	
pharmacological, cognitive and 
neural mechanisms. 
By using new methods of A differentiated view of negative symptom holistically and	 caring for
domains on pathophysiological models could
improve the integration of biological and
collecting data, such as National their mental,	 neurological 
Institute of Health Research psychological treatments, ultimately leading to and physical	 health is the 
Domain Criteria, or the European the development of individualized treatment best way to treat the needsRoadmap for Mental Health programs (Begue et al, 2020). of the patient.Research, diagnosis could be
broken down into underlying
phenotypes and schizophrenia 
treatment could be improved
(Falkai et al, 2018).
The current method of
assessment contains many
unexplained variables, and with a 
better understanding of the 
underlying methods for treating
schizophrenia patients could be
improved if they were broken
down into both clinical and 
neurobiological entities. Social-
skills training, arts and body-
oriented therapies could improve 
emotional expression and
interpersonal functioning (Begue 
et al, 2020). 
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Continuous disturbance for 6 months (attenuated 
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